Back
For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".
To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".
During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center.
Preparing your E-Poster
Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.
E-Poster Submission Deadline
Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.
Please follow the instructions below to input your abstract title.
Abstract titles should be brief and reflect the content of the abstract.
Glucocorticoids have diverse adverse effects, particularly infections that may be severe or opportunistic. Therefore, glucocorticoids are often started with the patient hospitalized, however, the optimal glucocorticoid dose at discharge remains uncertain. This study examined whether the discharge dose of glucocorticoids influences infection onset and rehospitalization in patients with renal disease.
This was a multicenter retrospective cohort study conducted at eight hospitals from 2013 to 2023. Adults initiated on oral prednisolone ≥30 mg/day during hospitalization for renal disease were included. The primary outcome was infection within 30 days of discharge; secondary outcomes were rehospitalization for infection and unplanned rehospitalization for any cause. Logistic regression analyses were performed to evaluate primary and secondary outcomes, using glucocorticoid dose and other potential confounding factors as explanatory variables.
Among 684 patients, 24 (3.5%) developed infections within 30 days, including 17 bacterial (11 pneumonia), 5 fungal, and 2 cytomegalovirus infections; 17 patients (2.5%) required rehospitalization for infection. Overall, 51 patients (7.4%) had unplanned rehospitalization, most often for edema control, primary-disease relapse, or dehydration/electrolyte imbalance. Glucocorticoid dose at discharge was not significantly associated with infection onset or rehospitalization at any dose cutoffs. In contrast, glucocorticoid pulse therapy, older age and reduced renal function were associated with increased rehospitalization risk.
Higher discharge doses of oral glucocorticoids did not increase infection or rehospitalization rates. Discharge timing should therefore be individualized based on overall patient risk rather than glucocorticoid dose alone.
